Procyanidins mediates antineoplastic effects against non-small cell lung cancer via the JAK2/STAT3 pathway

Yue Wu; Chi Liu; Yuxu Niu; Jiamin Xia; Liwen Fan; Yun Wu; Wen Gao

doi:10.21037/tcr-20-3018

Procyanidins mediates antineoplastic effects against non-small cell lung cancer via the JAK2/STAT3 pathway

Transl Cancer Res. 2021 May;10(5):2023-2035. doi: 10.21037/tcr-20-3018.

Authors

Yue Wu^#^{1

2}, Chi Liu^#¹, Yuxu Niu^#^{1

2}, Jiamin Xia³, Liwen Fan^{1

2}, Yun Wu^{1

2}, Wen Gao^{1

2}

Affiliations

¹ Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital, Fudan University, Shanghai, China.
² Department of Thoracic Surgery, Huadong Hospital, Fudan University, Shanghai, China.
³ Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

^# Contributed equally.

Abstract

Background: Lung cancer is a malignant tumor with one of the highest rates of cancer-related morbidity and mortality worldwide. Non-small cell lung cancer (NSCLC) account for 85% of all lung cancers and have a poor prognosis. Proanthocyanidins (PCs) are polyphenolic compounds that are found widely in natural plants. The present study aimed to determine the effects of PC on lung cancer and identify its possible mechanism.

Methods: A cell growth assay was used to detect the cell growth ability of A549 cancer cells, and a clonal formation assay was used to detect the cloning ability of A549 cancer cells. Flow cytometry was used to detect the effect of PCs on apoptosis and the cell cycle. The wound healing test, Transwell migration, and invasion test were used to detect the migration and invasion of human NSCLC A549 cells. Western blotting was utilized to detect the expression levels of N-cadherin, E-cadherin, vimentin, Janus kinase 2 (JAK2), p-signal transducer and activator of transcription 3 (p-STAT3), STAT3, matrix metalloproteinase 2 (MMP-2), MMP-9, and the apoptosis-related proteins, B-cell lymphoma-2 (Bcl-2) and BCL2-associated X (Bax). Cell immunofluorescence was used to detect the expression levels of the p-STAT3 primary antibody.

Results: PCs reduced the proliferation and cloning ability of A549 cells and significantly inhibited the migration and invasion of A549 cells in a dose-dependent manner. At the same time, PCs induced apoptosis in A549 cells and G2/M cell cycle arrest. PCs increased the pro-apoptotic protein expression, Bax, and down-regulated the anti-apoptotic protein expression, Bcl-2. PCs also inhibited the epithelial-mesothermal transition (EMT) process of A549 cells. We also found that the JAK2/STAT3 signaling pathway inhibitor, AG490, cooperated with PCs to inhibit A549 cell invasion and migration. Our results demonstrated that PCs could mediate the antitumor effect of NSCLC via the JAK2/STAT3 pathway.

Conclusions: PCs can inhibit NSCLC A549 cell proliferation, invasion, metastasis, clone formation, EMT, and induced apoptosis and G2/M cell cycle arrest. They work by inhibiting the JAK2/STAT3 signaling pathway. As a novel antitumor drug, PCs have broad application prospects for the treatment of NSCLC.

Keywords: Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3); Proanthocyanidins; epithelial-mesothermal transition (EMT); non-small cell lung cancer (NSCLC).